Eagle Pharmaceuticals (EGRX) Insider Trading & Ownership $0.65 -0.25 (-27.66%) (As of 11/19/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Eagle Pharmaceuticals (NASDAQ:EGRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.90%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.13 M Get EGRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eagle Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EGRX Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Eagle Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2023Scott TarriffCEOSell10,925$13.82$150,983.50 10/2/2023Scott TarriffCEOSell9,511$15.23$144,852.53 5/15/2023Scott TarriffCEOSell15,000$21.07$316,050.00 5/11/2023Scott TarriffCEOSell15,000$20.71$310,650.00 9/6/2022Richard A EdlinDirectorSell6,800$30.99$210,732.00 (Data available from 1/1/2013 forward) EGRX Insider Trading Activity - Frequently Asked Questions Who is on Eagle Pharmaceuticals's Insider Roster? The list of insiders at Eagle Pharmaceuticals includes Richard A Edlin, and Scott Tarriff. Learn more on insiders at EGRX. What percentage of Eagle Pharmaceuticals stock is owned by insiders? 28.90% of Eagle Pharmaceuticals stock is owned by insiders. Learn more on EGRX's insider holdings. Which Eagle Pharmaceuticals insiders have been selling company stock? The following insider sold EGRX shares in the last 24 months: Scott Tarriff ($922,536.03). How much insider selling is happening at Eagle Pharmaceuticals? Insiders have sold a total of 50,436 Eagle Pharmaceuticals shares in the last 24 months for a total of $922,536.03 sold. Eagle Pharmaceuticals Key ExecutivesMr. Michael Graves (Age 61)Interim Principal Executive Officer & Executive Chairman of the Board Compensation: $160kMr. Steven B. Ratoff (Age 81)Interim CFO, Principal Accounting Officer & Director Compensation: $100kMr. Daniel O'Connor (Age 44)Executive VP, Chief Strategy Officer & Head of Corporate Development Dr. Valentin R. Curt M.D.Senior Vice President of Clinical Drug DevelopmentDr. Gaozhong Zhu Ph.D.Senior Vice President of Pharmaceutical DevelopmentMs. Debra Marie Hussain (Age 56)Senior VP & Head of Commercial Mr. Reed McClungExecutive Vice President of Oncology Business Development More Insider Trading Tools from MarketBeat Related Companies ANEB Insider Selling RLYB Insider Selling DRRX Insider Selling VTVT Insider Selling CLNN Insider Selling ELEV Insider Selling OKYO Insider Selling PASG Insider Selling VRCA Insider Selling CALC Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:EGRX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
